NO163595C - Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin. - Google Patents

Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin.

Info

Publication number
NO163595C
NO163595C NO822218A NO822218A NO163595C NO 163595 C NO163595 C NO 163595C NO 822218 A NO822218 A NO 822218A NO 822218 A NO822218 A NO 822218A NO 163595 C NO163595 C NO 163595C
Authority
NO
Norway
Prior art keywords
phenylacetylaminopiperidine
dion
urine
preparing
procedure
Prior art date
Application number
NO822218A
Other languages
English (en)
Norwegian (no)
Other versions
NO163595B (no
NO822218L (no
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of NO822218L publication Critical patent/NO822218L/no
Publication of NO163595B publication Critical patent/NO163595B/no
Publication of NO163595C publication Critical patent/NO163595C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO822218A 1981-07-02 1982-06-29 Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin. NO163595C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27972881A 1981-07-02 1981-07-02
US06/330,383 US4470970A (en) 1981-07-02 1981-12-15 Purified antineoplaston fractions and methods of treating neoplastic disease

Publications (3)

Publication Number Publication Date
NO822218L NO822218L (no) 1983-01-03
NO163595B NO163595B (no) 1990-03-19
NO163595C true NO163595C (no) 1990-06-27

Family

ID=26959856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822218A NO163595C (no) 1981-07-02 1982-06-29 Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin.

Country Status (14)

Country Link
US (1) US4470970A (ja)
EP (1) EP0069232B1 (ja)
JP (3) JPH0729925B2 (ja)
AU (1) AU551109B2 (ja)
CA (1) CA1188218A (ja)
DE (1) DE3273952D1 (ja)
DK (2) DK162813C (ja)
ES (1) ES8502417A1 (ja)
HK (1) HK30289A (ja)
IL (1) IL65960A (ja)
MY (1) MY102918A (ja)
NO (1) NO163595C (ja)
NZ (1) NZ200805A (ja)
SG (1) SG4489G (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
AU7742491A (en) * 1990-04-12 1991-11-11 Stereo-Chemical Genetics, Inc. Synthetic piperidinediones with cytostatic activity
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
EP0567613B1 (en) * 1991-10-21 2002-02-20 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Compositions for therapy and prevention of cancer
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) * 1995-02-27 1998-07-21 Kuo; Sheng-Chu Helper inducers for differentiation therapy and chemoprevention of cancer
CA2254772C (en) * 1996-05-14 2004-01-27 Stanislaw R. Burzynski Liposomal antineoplaston therapies with markedly improved antineoplastic activity
EP2298350A3 (en) * 1996-07-26 2011-06-08 Susan P. Perrine Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
AU1553799A (en) * 1998-12-18 2000-07-12 Chang, Ming-Lieh Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
NZ538405A (en) * 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE463549A (ja) *
GB2003887A (en) * 1977-09-06 1979-03-21 Nyegaard & Co As Isolation of peptides from urine
JPS57115330A (en) * 1981-01-08 1982-07-17 Toshiba Mach Co Ltd Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) * 1989-10-19 1999-05-31 東洋紡績株式会社 熱可塑性樹脂フィルム積層物

Also Published As

Publication number Publication date
AU8423982A (en) 1983-01-06
US4470970A (en) 1984-09-11
NO163595B (no) 1990-03-19
JPH0780764B2 (ja) 1995-08-30
ES512894A0 (es) 1985-01-01
EP0069232B1 (en) 1986-10-29
HK30289A (en) 1989-04-21
DK242082A (da) 1983-01-03
JPS5810521A (ja) 1983-01-21
NO822218L (no) 1983-01-03
CA1188218A (en) 1985-06-04
IL65960A0 (en) 1982-09-30
JPH0739390B2 (ja) 1995-05-01
ES8502417A1 (es) 1985-01-01
JPH0558886A (ja) 1993-03-09
SG4489G (en) 1989-05-26
JPH0532548A (ja) 1993-02-09
DK143491D0 (da) 1991-08-06
CA1262907C (ja) 1989-11-14
JPH0729925B2 (ja) 1995-04-05
NZ200805A (en) 1986-08-08
EP0069232A2 (en) 1983-01-12
DK162813B (da) 1991-12-16
DE3273952D1 (en) 1986-12-04
DK143491A (da) 1991-08-06
IL65960A (en) 1985-11-29
MY102918A (en) 1993-03-31
EP0069232A3 (en) 1984-07-04
AU551109B2 (en) 1986-04-17
DK162813C (da) 1992-05-04

Similar Documents

Publication Publication Date Title
NO163595C (no) Fremgangsmaate for fremstilling av forbindelsen 3-(n-fenylacetylaminopiperidin)-2,6-dion fra urin.
ES520638A0 (es) Procedimiento de preparar compuestos carbostirilicos.
ES507493A0 (es) Procedimiento de preparar compuestos benzoheterociclicos.
FI823757L (fi) Cis-endo-2-azabicyklo/3,3.0/oktan-3-karboxylsyraderivat, foerfarande foer deras framstaellning, desinnehaollande aemnen och deras anvaendning
NO912848L (no) Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.
ES509449A0 (es) "un procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-3,4-c-piridina".
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
ES521545A0 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ES507545A0 (es) Procedimiento de preparar compuestos carbostirilicos.
ES517022A0 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
NO158061C (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-metyl-n-2-pyridyl-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyd (piroxicam).
NO822410L (no) Fremgangsmaate ved fremstilling av benzothiazolsulfonamid-derivater.
ES504321A0 (es) Un procedimiento para la preparacion de derivados de oxazolidin-2,4-diona 5-heterociclico sustituidos.
ES515419A0 (es) Un procedimiento de preparacion de nuevos derivados de 4h-1,2,4-triazol.
NO158743C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser.
ES521140A0 (es) Procedimiento para preparar derivados de dibenzo(de,g)quinoleina.
NO154547C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
FI73980B (fi) Foerfarande foer framstaellning av (-)-2-/1-(2,6-diklorfenoxi)-etyl-/1,3-diazacyklopent-2-en.
ES510596A0 (es) Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo.
ES517471A0 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
NO830046L (no) Fremgangsmaate for fremstilling av 6-aminoalkylpenicillansyre-1,1-dioksyder.
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
NO158621C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
ES512696A0 (es) "procedimiento de obtener compuestos metilquinoxalin-1,4-dioxidicos".

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JUNE 2002